News
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the pricing of an underwritten registered offering of 15,790,000 shares of its common s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback